Ikk-.beta. proteins, nucleic acids and methods
CA 2294516 C · Owner: Woronicz, John · Inventors: Goeddel, David V.; Woronicz, John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides methods and compositions relating to an I.kappa.B kinase, IKK-.beta. and related nucleic acids. The polypeptides may be produced recombinantly from transformed host cells from the disclosed IKK- .beta. encoding nucleic acids or purified from human cells. The invention provides isolated IKK-.beta. hybridization probes and primers capable of specifically hybridizing with the disclosed IKK-.beta. genes IKK-.beta.-specific binding agents such as specific antibodies and methods of , making and using the subject compositions in diagnosis therapy, and in the biopharmaceutical industry.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 1, 1998 and granted October 21, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 1, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 1, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.